| MSD Merck Sharp & Dohme AG - Vaxneuvance, Injektionssuspension |
| 68752 | | 01 | | Vaxneuvance | | Injektionssuspension | | J07AL02 | | Pneumococcus, Purified Polysaccharides Antigen Conjugated | | 14.02.2023 | | |
|
| Composition |
| polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg et polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg corresp. polysaccharida 32 µg et proteinum corynebacteriae diphtheriae CRM 197 ca. 30 µg, adjuvans: aluminium 0.125 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.77 mg, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. |
| Packungsbestandteile |
| | | | | | | | | Active Agent | Dose |
|---|
| | 2µg / 0.5ml | | | 2µg / 0.5ml | | | 2µg / 0.5ml | | | 2µg / 0.5ml | | | 2µg / 0.5ml | | | 2µg / 0.5ml correspond Polysaccharida 32µg / 0.5ml | | | 2µg / 0.5ml | | | 4µg / 0.5ml | | | 2µg / 0.5ml | | | 2µg / 0.5ml |
| | | | | Inactive agents | Dose | additional_information |
|---|
| Aluminium | 0.125mg / 0.5ml | adjuvans | | | 2µg / 0.5ml | | | Histidinum | | | | Natrii Chloridum | | | | | 14 | | | | | | | | 30µg / 0.5ml | |
| |
|
|
